ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P18
Within normal range
vs 5Y Ago
-2.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -51.36% |
| Q3 2025 | 10.45% |
| Q2 2025 | 67.83% |
| Q1 2025 | -87.43% |
| Q4 2024 | 385.09% |
| Q3 2024 | 3.97% |
| Q2 2024 | 100.11% |
| Q1 2024 | -56.47% |
| Q4 2023 | 160.48% |
| Q3 2023 | -2002.40% |
| Q2 2023 | 105.67% |
| Q1 2023 | -16.33% |
| Q4 2022 | -49.24% |
| Q3 2022 | 8.28% |
| Q2 2022 | 70.22% |
| Q1 2022 | -153.08% |
| Q4 2021 | -191.86% |
| Q3 2021 | 64.99% |
| Q2 2021 | 34.54% |
| Q1 2021 | 0.58% |
| Q4 2020 | 21.81% |
| Q3 2020 | -95.18% |
| Q2 2020 | 50.84% |
| Q1 2020 | -58.72% |
| Q4 2019 | -24.17% |
| Q3 2019 | 20.44% |
| Q2 2019 | 34.85% |
| Q1 2019 | -30.26% |
| Q4 2018 | -9.80% |
| Q3 2018 | 4.38% |
| Q2 2018 | -16.89% |
| Q1 2018 | 21.70% |
| Q4 2017 | -5.58% |
| Q3 2017 | 3.10% |
| Q2 2017 | 22.94% |
| Q1 2017 | -13.52% |
| Q4 2016 | -8.06% |
| Q3 2016 | -0.66% |
| Q2 2016 | -43.10% |
| Q1 2016 | -10.31% |